{"date":"2026-02-23","count":53,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6649-2026-02-23-2227-15z6ddo","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"22:27:21","subject":"公告本公司114年第四季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2026-02-23 22:27，「公告本公司114年第四季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-02-23-2204-1yl2a8g","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"22:04:17","subject":"公告本公司接獲專利侵權訴訟起訴狀","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-02-23 22:04，「公告本公司接獲專利侵權訴訟起訴狀」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-02-23-2125-lwqvcw","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-02-23","time":"21:25:39","subject":"代重要子公司Belite Bio, Inc公告114年第4季法人說明會將於115年3月3日召開","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-02-23 21:25，「代重要子公司Belite Bio, Inc公告114年第4季法人說明會將於115年3月3日召開」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-02-23-1935-73ywju","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-02-23","time":"19:35:06","subject":"本公司董事會通過子公司Alvogen Pharma US與Solaxa簽訂SLX100授權合約共同開發並取得全球獨家銷售權","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-02-23 19:35，「本公司董事會通過子公司Alvogen Pharma US與Solaxa簽訂SLX100授權合約共同開發並取得全球獨家銷售」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2026-02-23-1907-15z6ddo","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"19:07:42","subject":"公告本公司114年第四季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-02-23 19:07，「公告本公司114年第四季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-02-23-1834-16mn4ih","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"18:34:39","subject":"本公司擬處份部份子公司佑全藥品股份有限公司股權案。","clause":"第20款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-02-23 18:34，「本公司擬處份部份子公司佑全藥品股份有限公司股權案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-02-23-1834-q1wnzv","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"18:34:07","subject":"公告本公司董事會通過總經理異動案","clause":"第6款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-02-23 18:34，「公告本公司董事會通過總經理異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-02-23-1830-bwopfv","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"18:30:11","subject":"公告本公司董事會決議不分派股利","clause":"第14款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-02-23 18:30，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-02-23-1829-5j9yh6","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"18:29:33","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-02-23 18:29，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-02-23-1828-12b8n2r","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"18:28:22","subject":"優盛醫學科技股份有限公司董事會決議召開115年股東常會公告","clause":"第17款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-02-23 18:28，「優盛醫學科技股份有限公司董事會決議召開115年股東常會公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-02-23-1817-l3trla","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"18:17:23","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月3日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-02-23 18:17，「公告本公司114年度財務報告董事會預計召開日期為115年3月3日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2026-02-23-1812-z1xoqs","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"18:12:53","subject":"公告114年度財務報告董事會預計召開日期為115年3月3日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-02-23 18:12，「公告114年度財務報告董事會預計召開日期為115年3月3日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-02-23-1812-1iiq7nq","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-02-23","time":"18:12:27","subject":"公告本公司114年度個體暨合併財務報告董事會預計召開日期為115年3月3日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-02-23 18:12，「公告本公司114年度個體暨合併財務報告董事會預計召開日期為115年3月3日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2026-02-23-1747-13rr8wl","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"17:47:51","subject":"114年度財務報告董事會預計召開日期為115年3月4日","clause":"第31款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2026-02-23 17:47，「114年度財務報告董事會預計召開日期為115年3月4日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1777-2026-02-23-1732-13bqai2","company_id":"1777","company":"生泰","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"17:32:30","subject":"本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：生泰（1777），2026-02-23 17:32，「本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1777-2026-02-23-1731-hurcou","company_id":"1777","company":"生泰","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"17:31:45","subject":"本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：生泰（1777），2026-02-23 17:31，「本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1777-2026-02-23-1731-wlvldv","company_id":"1777","company":"生泰","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"17:31:01","subject":"公告本公司114年度財務報告業經董事會決議通過","clause":"第31款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：生泰（1777），2026-02-23 17:31，「公告本公司114年度財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-02-23-1724-1howjn","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"17:24:57","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-02-23 17:24，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-02-23-1722-bwopfv","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"17:22:37","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-02-23 17:22，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-02-23-1721-5j9yh6","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"17:21:20","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-02-23 17:21，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-02-23-1720-1kmb7k2","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"17:20:19","subject":"公告本公司董事會決議以私募方式辦理現金增資發行普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-02-23 17:20，「公告本公司董事會決議以私募方式辦理現金增資發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-02-23-1719-1d6oq6c","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"17:19:04","subject":"公告本公司董事會決議辦理已發行之限制員工權利新股收回註銷減資事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-02-23 17:19，「公告本公司董事會決議辦理已發行之限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2026-02-23-1717-1aan03u","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2026-02-23","time":"17:17:27","subject":"公告本公司收到「用於上呼吸道給藥之組成物及其給藥方法」之加拿大專利核准通知書","clause":"第44款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2026-02-23 17:17，「公告本公司收到「用於上呼吸道給藥之組成物及其給藥方法」之加拿大專利核准通知書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2026-02-23-1717-nxreki","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"17:17:07","subject":"公告本公司董事會決議召開一百一十五年股東常會事宜","clause":"第17款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2026-02-23 17:17，「公告本公司董事會決議召開一百一十五年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2026-02-23-1715-bwopfv","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"17:15:50","subject":"公告本公司董事會決議不分派股利","clause":"第14款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2026-02-23 17:15，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-02-23-1714-9pd2l0","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-02-23","time":"17:14:20","subject":"本公司受邀參加由Morgan Stanley舉辦之法說會「Taiwan Discovery Forum: Spotlight on Taiwan Non-Tech」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-02-23 17:14，「本公司受邀參加由Morgan Stanley舉辦之法說會「Taiwan Discovery Forum: Spotlig」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-02-23-1711-15c4a2c","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-02-23","time":"17:11:34","subject":"本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之亞太二期臨床試驗CBL-0206，已於2/17完成澳洲主管機關HREC申請(補充說明第三期臨床試驗於美國及加拿大已核准執行)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-02-23 17:11，「本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之亞太二期臨床試驗CBL-0206，已於2/17完成澳洲主管機關HRE」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2026-02-23-1708-17mlv4t","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"17:08:31","subject":"(更正提案期間)公告本公司董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2026-02-23 17:08，「(更正提案期間)公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2026-02-23-1651-1xl66gd","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"16:51:14","subject":"公告本公司董事會通過114年度個別財務報告","clause":"第31款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2026-02-23 16:51，「公告本公司董事會通過114年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2026-02-23-1647-1lw20g9","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"16:47:30","subject":"更正公告本公司114年第四季個別財務報告預計提報董事會年度(更正事實發生年度、董事會召集通知年度、董事會預計召開年度)","clause":"第31款","fact_date":"2026-02-13","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2026-02-23 16:47，「更正公告本公司114年第四季個別財務報告預計提報董事會年度(更正事實發生年度、董事會召集通知年度、董事會預計召開年度)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2026-02-23-1646-1howjn","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"16:46:00","subject":"公告本公司董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2026-02-23 16:46，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2026-02-23-1636-1s5glfa","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"16:36:07","subject":"公告114年度財務報告董事會召開日期","clause":"第31款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2026-02-23 16:36，「公告114年度財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-02-23-1633-1df0yg3","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-02-23","time":"16:33:51","subject":"代子公司「中化裕民健康事業股份有限公司」公告其董事會通過員工酬勞及董監事酬勞分派議案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-02-23 16:33，「代子公司「中化裕民健康事業股份有限公司」公告其董事會通過員工酬勞及董監事酬勞分派議案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-02-23-1632-19ltzf9","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-02-23","time":"16:32:58","subject":"代本公司重要子公司中化裕民健康事業股份有限公司公告其董事會決議發放114年度股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-02-23 16:32，「代本公司重要子公司中化裕民健康事業股份有限公司公告其董事會決議發放114年度股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2026-02-23-1630-11wjw0o","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"16:30:48","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2026-02-23 16:30，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2026-02-23-1627-5j9yh6","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"16:27:59","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2026-02-23 16:27，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2026-02-23-1624-khipx8","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2026-02-23","time":"16:24:15","subject":"公告本公司董事會通過更換股務代理機構","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2026-02-23 16:24，「公告本公司董事會通過更換股務代理機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-02-23-1609-f7zdi0","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"16:09:53","subject":"公告本公司114年度財務報告董事會召開日期","clause":"第31款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-02-23 16:09，「公告本公司114年度財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8279-2026-02-23-1609-hurcou","company_id":"8279","company":"生展","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"16:09:48","subject":"本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：生展（8279），2026-02-23 16:09，「本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-02-23-1608-zlq9nb","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"16:08:46","subject":"授權夥伴專案進展更新","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-02-23 16:08，「授權夥伴專案進展更新」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2026-02-23-1607-rqdtpj","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-02-23","time":"16:07:02","subject":"代子公司開啟基因股份有限公司公告法人董事代表人異動暨董事變動達三分之一","clause":"第6款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2026-02-23 16:07，「代子公司開啟基因股份有限公司公告法人董事代表人異動暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2026-02-23-1606-74bu1l","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-02-23","time":"16:06:44","subject":"公告本公司市場營銷處副總經理辭任","clause":"第11款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2026-02-23 16:06，「公告本公司市場營銷處副總經理辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8279-2026-02-23-1600-1t218b2","company_id":"8279","company":"生展","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"16:00:21","subject":"公告本公司董事會決議發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生展（8279），2026-02-23 16:00，「公告本公司董事會決議發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8279-2026-02-23-1540-vsk5u","company_id":"8279","company":"生展","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"15:40:20","subject":"公告本公司董事會通過民國114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生展（8279），2026-02-23 15:40，「公告本公司董事會通過民國114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2026-02-23-1512-a5wbsz","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2026-02-23","time":"15:12:09","subject":"公告本公司於證券法規遵循輔導契約存續期間內終止委任證券承銷商","clause":"第7款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2026-02-23 15:12，「公告本公司於證券法規遵循輔導契約存續期間內終止委任證券承銷商」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2026-02-23-1506-1re1pst","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2026-02-23","time":"15:06:16","subject":"公告本公司114年度合併財務報告及個體財務報告董事會預計召開日期為115年03月03日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2026-02-23 15:06，「公告本公司114年度合併財務報告及個體財務報告董事會預計召開日期為115年03月03日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2026-02-23-1501-p7uqfs","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"15:01:37","subject":"公告本公司民國114年度財務報告董事會召開日期","clause":"第31款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2026-02-23 15:01，「公告本公司民國114年度財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-02-23-1500-10tlgef","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-02-23","time":"15:00:33","subject":"公告本公司114年度現金增資收足股款暨訂定增資基準日","clause":"第44款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-02-23 15:00，「公告本公司114年度現金增資收足股款暨訂定增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-02-23-1438-1au96ij","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-02-23","time":"14:38:29","subject":"睿生光電2026年上半年法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-02-23 14:38，「睿生光電2026年上半年法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-02-23-1437-1l6p2m4","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-02-23","time":"14:37:25","subject":"公告本公司民國114年第四季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-02-23 14:37，「公告本公司民國114年第四季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-02-23-1425-1bjreho","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-02-23","time":"14:25:28","subject":"公告本公司與Arrotex Pharmaceuticals簽署眼部術後炎症和疼痛治療新藥APP13007於澳洲及紐西蘭市場之獨家授權合約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-02-23 14:25，「公告本公司與Arrotex Pharmaceuticals簽署眼部術後炎症和疼痛治療新藥APP13007於澳洲及紐西蘭市」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2026-02-23-1419-7vlfa1","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"14:19:26","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月4日","clause":"第31款","fact_date":"2026-02-23","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2026-02-23 14:19，「公告本公司114年度財務報告董事會預計召開日期為115年3月4日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-02-23-1335-1wc7x5x","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-02-23","time":"13:35:23","subject":"公告本公司114年第4季財務報告董事會預計召開日期為115年3月3日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-02-23 13:35，「公告本公司114年第4季財務報告董事會預計召開日期為115年3月3日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}